U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618000) titled 'PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition' on May 26.
Brief Summary: The expected outcome of this study is that continuous 8-week supplementation with the PI-YSP-0111 prebiotic formulation will exert beneficial effects on gut microbiota modulation and liver health.
Study Start Date: April 08
Study Type: INTERVENTIONAL
Condition:
Heathly Volunteers
Intervention:
DIETARY_SUPPLEMENT: PI-YSP-0111 formulation (High-dose)
6 per day(Lactobacillus rhamnosus MB17, Lactobacillus plantarum MB-10, Grape Seed extract, Oligo, Wofberry Extract Powder, Maltose powder, Aerosil, Magnesium Stearate)
DIETARY_SUPPLEMENT...